An association between the DRD2 Taq1A (C32806T) polymorphism and social alcohol consumption in the opposite direction to that reported for alcoholism has recently been reported in a male Finnish sample. We attempted to replicate these findings in two independent samples, and extend on previous work by including female participants. The DRD2 A1 allele was significantly associated with reduced alcohol consumption in sample one (P ¼ 0.004) and sample two (P ¼ 0.015). In sample two there was a significant genotype Â sex interaction (P ¼ 0.016), with the association of the A1 allele and reduced alcohol consumption significant in men only. This interaction was marginally significant (P ¼ 0.042) in a meta-analysis of combined data from both samples, and the main effect of genotype highly significant (Po0.001). Age at time of data collection and cigarette consumption were entered as covariates in all analyses. These results replicate recent previous findings and suggest a possibility that this association may exist in men only, or be stronger in men. 
INTRODUCTION
The human central dopamingeric system is widely considered to play an important role in substance use and the development of subsequent dependence. Evidence for a role for this system extends to a range of psychoactive substances, including opiates, cocaine, nicotine and alcohol. [1] [2] [3] As a consequence, in attempting to elucidate the genetic determinants of substance use, a great deal of attention has been paid to the potential role of candidate genes related to individual variation in dopaminergic function. In particular, the dopamine D2 receptor (DRD2) gene on chromosome 11 (q22-q23) has been widely studied. 4 The DRD2 gene is highly polymorphic, but much attention has focussed on the Taq1A (C32806T) polymorphism, a C4T substitution located in a noncoding region of the DRD2 locus, which has been suggested to affect dopamine receptor D2 availability in post-mortem striatal samples. 5, 6 There is also evidence from in vivo studies for an association between the A1 (T) allele and lower mean relative glucose metabolic rate in dopaminergic regions in the human brain, 7 and PET studies have indicated that this allele is also associated with low receptor density. 8, 9 Recent work shows that the Taq1A site is an amino-acid changing single-nucleotide polymorphism in a previously undescribed protein kinase gene near the DRD2 locus. 10 The precise functional role of the Taq1A locus, however, still remains unknown.
Several studies have reported an association between the DRD2 Taq1A1 allele and alcoholism, in particular among Caucasian participants, although this association remains the subject of some controversy, [11] [12] [13] [14] [15] [16] [17] partly due to the difficulty in adequately defining alcoholic case status in a comparable way across studies. The use of continuously distributed dependent variables can afford greater statistical power to detect genetic association, although this is problematic when risk of psychiatric case status is the phenotype under investigation.
Recently, however, an association between the DRD2 Taq1A1 allele and continuously distributed self-reported alcohol consumption (calculated as grams per week of pure ethanol, from questionnaire responses) in a representative, ethnically homogeneous, nonalcoholic, human male population in eastern Finland has been reported. 18 This represents the first published report of an association between the DRD2 Taq1A polymorphism and social alcohol consumption (instead of alcoholic case status). Although the association was modest and mainly suggestive, the data indicated an association in the opposite direction to that typically reported between the A1 allele and alcoholism, with the A1 allele being associated with lower self-reported alcohol consumption. The authors concluded that this might be due to the suggested association between the A1 allele and low D2 receptor density, so that those with the A1A1 genotype may be less sensitive to the dopaminergic effects of alcohol, which is supported by evidence from the animal literature that mice lacking D2 receptors consume less ethanol than wild-type mice. 19 Moreover, the aetiology of social drinking compared to alcoholism may differ considerably, which might explain the discrepant results in this study compared to those of alcoholism. However, as the authors rightly conclude, there is a need for further research into this putative association.
We attempted to replicate these findings in two independent, representative, ethnically homogeneous, nonalcoholic, human samples in the United Kingdom. We also extended on the previous report 18 by including male and female participants in order to determine whether any association between the DRD2 Taq1A polymorphism and social alcohol consumption is restricted to males only or exists in males and females.
RESULTS

Sample One
The genotype distribution of study sample one did not deviate significantly from Hardy-Weinberg equilibrium (P ¼ 0.82). There was no significant difference in the overall genotype distribution between included participants and excluded participants (P ¼ 0.969). Participants had a mean age of 51 years 5 months (SD ¼ 8 years 9 months) and smoked an average of 14.20 cigarettes per day (SD ¼ 9.52). Females were slightly over-represented in the sample (55.6%).
A between-subjects 2 Â 2 analysis of variance, with DRD2 genotype (A1A1 þ A1A2, A2A2) and sex (male, female) as between-subjects factors was performed on log transformed self-reported alcohol consumption (U/week). Age at the time of data collection (years) and cigarette consumption (cigarettes per day) were included as covariates.
The Means for self-reported weekly alcohol consumption by genotype group for men and women in sample one are presented in Table 1 .
Sample Two
The genotype distribution of study sample two did not deviate significantly from Hardy-Weinberg equilibrium (P ¼ 0.99). There was no significant difference in the overall genotype distribution between participants and nonparticipants (P ¼ 0.40). Participants had a mean age of 50 years 10 months (SD ¼ 9 years 10 months) and smoked an average of 13.17 cigarettes per day (SD ¼ 12.10). Females were slightly over-represented in the sample (51.9%).
A between-subjects 2 Â 2 analysis of variance with DRD2 genotype (A1A1 þ A1A2, A2A2) and sex (male, female) as between-subjects factors was performed on log transformed self-reported alcohol consumption (U/week). Age at the time of data collection (years) and cigarette consumption (cigarettes per day) were included as covariates. Post hoc tests to clarify the nature of the DRD2 genotype Â sex interaction indicated that DRD2 genotype was associated with log transformed self-reported weekly alcohol consumption in men (P ¼ 0.003) but not in women (P ¼ 0.970).
Means for self-reported weekly alcohol consumption by genotype group for men and women in sample two are presented in Table 1 .
Meta-analysis
The presence of a significant DRD2 genotype Â sex interaction on self-reported weekly alcohol consumption in sample two but not sample one could not be readily explained in terms of differences in the genotype distribution or demographic characteristics of the two samples. There were no significant differences in mean age (P ¼ 0.338), sex distribution (P ¼ 0.259), cigarette consumption (P ¼ 0.153), alcohol consumption (P ¼ 0.850) or genotype distribution (P ¼ 0.215) between participants in sample one and sample two. One possible explanation for the difference between the results obtained in sample one and sample two may be that the statistical power to detect this interaction was marginal. We therefore performed a meta-analysis of the two data sets, using raw data.
A between-subjects 2 Â 2 Â 2 analysis of variance, with study (study one, study two), DRD2 genotype (A1A1 þ A1A2, A2A2) and sex (male, female) as between-subjects factors was performed on log transformed self-reported alcohol consumption (U/week). Age at the time of data collection (years) and cigarette consumption (cigarettes per day) were included as covariates.
This Post hoc tests to clarify the nature of the DRD2 genotype Â sex interaction indicated that DRD2 genotype was associated with log transformed self-reported weekly alcohol consumption in men (Po0.001) but not in women (P ¼ 0.177).
Mean self-reported weekly alcohol consumption by genotype group for men and women in the combined sample is presented in Table 1 .
DISCUSSION
We replicated and extended the findings of a recent study 18 demonstrating an association between the DRD2 Taq1A polymorphism and alcohol consumption among social drinkers in two independent samples drawn from the United Kingdom general population. Those possessing one or more copies of the A1 allele consumed less alcohol than those homozygous for the A2 allele. In one sample this association interacted with sex, and when the data from both samples were combined in a meta-analysis this interaction, as well as the main effect of genotype, remained Although we retained a combined A1A1/A1A2 group throughout our analyses due to the small number of A1 homozygotes, an inspection of means in the combined sample did not indicate any difference in self-reported weekly alcohol consumption between A1A1 and A1A2 individuals, in contrast to the findings in the Finnish sample. A further difference between our data and those previously reported is that in the Finnish sample the standard deviation of self-reported weekly alcohol consumption was somewhat smaller in the A1A1 group than in either the A1A2 or A2A2 groups. This finding was not replicated in our data, and may have arisen simply by chance in the Finnish sample, which illustrates the potential limitation of small numbers of participants in one genotype group (in this case A1A1).
The mean levels of alcohol consumption were somewhat higher in our study than in the previous report, 18 with the mean self-reported alcohol consumption among A2A2 men in our combined sample equivalent to 137 g of alcohol per week, compared to 97 g/week in the Finnish sample. In our combined sample, men possessing at least one copy of the A1 allele consumed 106 g/week, while in the Finnish sample A1A2 men consumed 82 g/week and A1A1 men 58 g/week. Therefore, although the direction and magnitude of effect was broadly comparable in our combined sample and the Finnish sample, the absolute levels of consumption appear to differ across these two samples.
The corresponding figures for alcohol consumption in women were somewhat lower in our sample compared to men, with A2A2 women consuming an average of 69 g of alcohol per week and those possessing at least one copy of the A1 allele consuming 64 g/week. It is well established that women, on average, consume less alcohol than men, in part due to differences compared to men in body mass and liver function, 20 which results in a greater effect of alcohol in women compared to men at a given level of consumption. Social factors may also influence levels of alcohol consumption in women compared to men, given the perceived acceptability of high levels of alcohol consumption in women. 21 One possibility, therefore, is that rather than the association between the DRD2 Taq1A polymorphism and alcohol consumption only operating in men, as suggested by the significant gene Â sex interaction we found, it may be the case that the lower absolute levels of alcohol consumption in women attenuate this effect. Certainly the direction of effect in women was the same as that observed in men, and the main effect of DRD2 genotype was highly significant. It is possible that our study was simply insufficiently powered to detect an association of smaller magnitude between the DRD2 Taq1A polymorphism and alcohol consumption in women. If this is the case a similar study conducted on a younger cohort of women might be better able to detect an association, given that younger women are now consuming higher levels of alcohol than the more elderly cohort investigated in this study. That is, the genotype Â sex interaction that we observed in our sample may be age-specific, and a different pattern of results might be obtained in a younger cohort. It should be borne in mind that the genotype Â sex interaction in our combined sample only marginally reached the criterion for statistical significance, and therefore should be regarded as suggestive only.
Given the reported association between the DRD2 Taq1A polymorphism and D2 receptor density, 9 one possible explanation for our results is that individuals possessing at least one copy of the A1 allele may not be as sensitive to the dopaminergic effects of alcohol consumption as those homozygous for the A2 allele. 18 This may, therefore, explain the opposite direction of effect found by both ourselves and the Finnish study 18 between the DRD2 Taq1A polymorphism and social alcohol consumption compared to alcoholism. It has been suggested that substance abuse is one potential consequence of 'reward deficiency syndrome', 22 a defective functioning of normal reward pathways, with substance abuse resulting from a desire to seek enhanced stimulation of reward pathways. If individuals possessing at least one copy of the A1 allele do indeed derive less reward from consuming alcohol then, in the absence of other factors that may contribute to the aetiology of alcoholism, the consequence may simply be reduced alcohol consumption. However, in genetically similar individuals who are exposed to, say, environmental stress from which relief is sought in alcohol consumption, a far greater amount of alcohol may need to be consumed in order to obtain this relief which, in turn, may contribute to the subsequent development of alcoholism. This possibility, although speculative, is supported by evidence that stress exposure mediates the association between the DRD2 Taq1A polymorphism and alcoholism. 23 Future studies should use longitudinal data to investigate the potential role of gene Â environment interactions in the progression from social drinking to alcohol dependence.
There are several important limitations to our study that should be borne in mind when considering these results. First, both of the samples used were ascertained for the explicit study of genetic associations with smoking behaviour, rather than alcohol consumption per se. We attempted to control for the possible confounding effects of any association between the DRD2 gene and smoking behaviour by excluding never smokers and including cigarette consumption as a covariate. Nevertheless, it would be desirable to replicate our findings in a cohort explicitly recruited for the purposes of studying alcohol consumption among social drinkers. It is advisable, however, when investigating genetic associations with social drug consumption (eg alcohol, nicotine, etc) that care should be taken to avoid potential confounding by collecting appropriate data on the consumption of a range of social drugs. Second, data were collected principally by self-report, although confirmed in face-to-face interview. Excessive alcohol consumption may be associated with consistent under-reporting of alcohol consumption, and we do not have biochemically validated alcohol consumption data. This limitation should be borne in mind when interpreting these results, and future studies DRD2 and alcohol consumption should endeavour to validate alcohol consumption data. Third, and relatedly, our data did not include diagnostic information regarding alcoholic case status. Although our exclusion criteria would have been likely to exclude participants with early-onset alcoholism, they may not have excluded participants with late-onset alcoholism. Given the possibility that an opposite pattern of association may exist between social alcohol consumption and alcoholism, this limitation should be borne in mind and future studies should collect more detailed clinical diagnostic information relating to alcoholism. Fourth, and finally, our exclusion criteria resulted in the exclusion of a relatively large number of participants from the original study samples, primarily participants that reported not consuming at least one unit of alcohol per week. This surprisingly large number of participants who reported not regularly consuming alcohol may reflect the age range of the study samples that we recruited. Moreover, this illustrates the importance of accurate phenotype definition in candidate gene studies; had we included these other participants this might have confounded two separate phenotypes of social alcohol consumption and occasional alcohol consumption or abstention. Future studies of alcohol use behaviours should include carefully specified continuous and categorical measures of these behaviours.
Nevertheless, the replication of the association between the DRD2 Taq1A polymorphism and social alcohol consumption first reported in a Finnish sample 18 in two independent, ethnically and geographically homogeneous samples of male and female social drinkers provides support for this association. The finding that the A1 allele is associated with reduced alcohol consumption suggests that the precise aetiology of alcoholism requires further elucidation and is likely to consist of a complex interaction of genetic and environmental risk factors. The potential genotype Â sex interaction that we describe warrants further investigation.
MATERIAL AND METHODS
Study Participants
The first study sample was drawn from 975 participants who were randomly selected from a healthy population-based cohort, aged 35-64, as part of a study of genetic associations with smoking behaviour. These data are reported elsewhere. 24 The original population-based cohort (n ¼ 8109) underwent a health check in 1989 with their general practitioner as part of the OXCHECK study. 25 Information was collected by structured face-to-face interview with trained nurses. Data collected included age, sex, body mass index, weekly alcohol consumption, ethnicity, socioeconomic class, smoking habits and medical history. Alcohol consumption was assessed by asking participants to report daily consumption of beer, lager or cider (pints), wine (glasses), sherry, vermouth or port (glasses), and spirits or liqueurs (single tots). Total weekly consumption was then converted to units (equivalent to 8 g ethanol) per week.
The second study sample was drawn from 755 participants, aged 33-73, who were recruited from general practices in Oxfordshire, UK, as part of a study of genetic associations with smoking cessation. These data are reported elsewhere. 26 The original cohort (n ¼ 1686) was recruited as part of a clinical trial of nicotine transdermal patch efficacy for smoking cessation. 27 Information was collected initially by postal questionnaire and confirmed at a subsequent faceto-face interview with a trained nurse. Data collected included age, sex, body mass index, weekly alcohol consumption, ethnicity and smoking habits. Alcohol consumption was assessed by asking participants to report weekly consumption of beer, lager or cider (pints), wine (glasses), sherry, vermouth or port (glasses), and spirits or liqueurs (single tots). Total weekly consumption was then converted to units (equivalent to 8 g ethanol) per week.
In the present study, participants from both study samples were included if they reported consuming at least 1 U of alcohol per week. Given evidence for an association between the DRD2 gene and alcohol dependency in the opposite direction to that which we predicted for social alcohol consumption, we excluded men who reported consuming greater than 50 U of alcohol per week and women who reported consuming greater than 35 U of alcohol per week in order to exclude potential alcohol dependent participants. Since the DRD2 gene has been reported to be associated with smoking status, 28 we excluded those who reported themselves to be never smokers (defined as reporting never having been a cigarette smoker). Finally, participants of nonCaucasian ethnicity were excluded.
The final study samples on which complete data were available, therefore, each consisted of an ethnically and geographically homogeneous group of male and female social drinkers (study sample one: n ¼ 383; study sample two: n ¼ 512). In both study samples the principal reason for exclusion was not consuming at least 1 U of alcohol per week (Sample 1: 67% of exclusions; Sample 2: 76% of exclusions). The study was approved by the local ethics committee (IRB).
Genotyping DNA was extracted from whole blood by standard procedures and participants genotyped for the DRD2 gene Taq1A polymorphism. The dopamine D2 receptor Taq1A RFLP is located downstream of the 3 0 untranslated region of DRD2 at position 32806 (Genbank Accession Number AF050737) and results from a C4T substitution. Genotyping was carried out by PCR using sequence specific primers using methods previously described. 29 Reactions were carried out for both common and variant alleles, each containing control primers which detected a conserved sequence in the adenomatosis polyposis coli (APC) gene, and eliminated the possibility of false negative results.
Allele-specific primers were 5 0 -CATCCTCAAAGTGCTGG TCG-3 0 (antisense) or 5 0 -CATCCTCAAAGTGCTGGTCA-3 0 (antisense), and 5 0 -CAGTGATACCTCTCCCCATG-3 0 (sense).
Statistical Analysis
A between-subjects 2 Â 2 analysis of variance, with DRD2 genotype (A1A1 þ A1A2, A2A2) and sex (male, female) as between-subjects factors, was performed on log transformed alcohol consumption (U/week). Age at the time of data collection (years) and cigarette consumption (cigarettes per day) were included as covariates. A1A1 and A1A2 genotype groups were combined due to the small number of A1 homozygotes (sample one: n ¼ 14; sample two: n ¼ 25). All analyses were performed using the Statistical Package for the Social Sciences, version 11.0. An alpha value of 0.05 was maintained throughout.
